Latest filing published 24 Nov 2020 for Quest Diagnostics INC, €596k.
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Daniel Stanzione is a declared insider at 3 companies; the most frequent names are Quest Diagnostics Inc, Internap Corp and Avaya Inc. Between 4 May 2006 and 23 November 2020, the trades on record add up to 84 filings.
Market trades split into 10 purchases (€275k) and 15 sales (€11.0M). Netting one side against the other leaves €10.7M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 37 share grants and 21 option exercises. In 2020 alone, the filings show no purchases and 3 sales.
A typical purchase (the median) is worth €26k. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 0% of cases; the median change was -1.0%. These figures describe past trades and do not predict future prices.
The latest filing, published on 24 November 2020, reports an open-market sale of €596k in Quest Diagnostics Inc. The latest purchase dates back some time: it was published 3,691 days ago, on 15 September 2016. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 82 declarations